Abstract
The purpose of this study was to evaluate the effect of endogenous gastrin on pancreatic regeneration after a partial pancreatectomy in the rat. Sixty rats were divided into 6 groups. Groups I and II received sham operation (splenectomy only), and groups III, IV, V, and VI received both 66% partial pancreatectomy (PPx) and splenectomy. Endogenous hypergastrinemia was induced in groups II, IV, and VI by gavage of Lansoprozole (LSP) for three weeks. In groups V and VI, gastrin receptor blocker, L365,260, was given continuously using an osmotic minipump. Following three weeks of treatment, PPx alone increased the pancreatic weight and protein content, but not RNA or DNA content (Group III). In the PPx groups, the pancreatic weight, and contents of protein, RNA, and DNA were significantly increased in the LSP treated rats (Group IV). This effect was abolished by L365,260 (Group VI). This results suggest that endogenous gastrin specifically stimulates regeneration of the remnant pancreas after partial pancreatectomy in rat. Induction of endogenous hypergastrinemia may be useful in patients following pancreatic resection for the prevention and treatment of pancreatic insufficiency.
Similar content being viewed by others
REFERENCES
Lev M, Fitzgerald PJ: Pancreatic acinar cell regeneration. IV. regeneration after surgical resection. Am J Pathol 53: 513–535, 1968
Pearson KW, Scott D, Torrance B: Effects of partial surgical pancreatectomy in rats. I. Pancreatic regeneration. Gastroenterology 72: 469–473, 1997
Mainz DL, Black O, Webster PD: Hormonal control of pancreatic growth. J Clin Invest 52: 2300–2304, 1973
Pfeiffer CJ, Chernenko GA, Kohli Y, Barrowman JA: Trophic effects of cholecystokinin octapeptide on the pancreas of the Syrian hamster. Can J Physiol Pharmacol 60: 358–362, 1982
Folsch UR: Regulation of pancreatic growth. Clin Gastroenterol 13: 679–699, 1984
Pap A, Berger Z, Varro V: Trophic effect of cholecystokininoctapeptide in man-a new way in the treatment of chronic pancreatitis? Digestion 21: 163–168, 1981
Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH Jr. Stimulation of in vivo pancreatic growth in the rat is mediated specifically by the way of cholecystokinin-A receptors. Gastroenterology 107: 1135–1146, 1994
Axelson J, Hakanson R, Ihse I, Lilja I, Rehfeld JF, Sundler F: Effect of endogenous and exogenous cholecystokinin and infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth. Scand J Gastroenterol 25: 471–480, 1990
Johnson LR: New aspect of the trophic action of gastrointestinal hormones. Gastroenterology 72: 788–792, 1977
Dembinski AB, Johnson LR: Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin. Endocrinology 106: 323–328, 1980
Solomon TE, Morisset J, Wood JG, Bussjaeger LJ: Additive interaction of pentagastrin and secretin on pancreatic growth in rats.Gastroenterology 92: 429–435, 1987
Petersen H, Solomon T, Grossman MI: Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats. Am J Physiol 234: E286–E293, 1978
Johson LR, Guthrie PD: Proglumide inhibition of trophic action of pentagastrin. Am J Physiol 246: G62–G66, 1984
Stock-Damge C, Lhoste E, Aprahamian M, Pousse A: Gastrin modulation of pancreatic growth. Scand J Gastroenterol 20(suppl 112): 68–74, 1985
Chu M, Kullman E, Rehfeld JF, Borch K: Effect of chronic endogenous hypergastrinemia on the pancreatic growth and carcinogenesis in the hamster. Gut 40: 536–540, 1997
Reber HA, Johnson F, Devency K, Montgomery C, Way LW: Trophic effects of gastrin on the exocrine pancreas in rats. J Surg Res 22: 554–560, 1977
Stock-Damge C, Aprahamian M, Lhoste E, Pousse A, Humbert W, Noriega R, Grenier JF: Pancreatic hyperplasia after small bowel resection in the rat: Dissociation from endogenous gastrin level. Digestion 29: 223–230, 1984
Dembinski AB, Johnson LR: Growth of pancreas and gastrointestinal mucosa in antrectomized and gastrin-treated rats. Endocrinology 105:769–773, 1979
Ballinger A, Ahmed M, Kumar P, Clark M: Gastrin effects on growth and exocrine secretion in the neonatal rat pancreas. Pancreas 14: 295–300, 1997
Niederau C, Niederau M, Klonowski H, Ferrell LD: Effect of hypergastrinemia and blockade of gastrin-receptors on pancreatic growth in the mouse. Hepatogastroenterology 42: 423–443, 1995
Kim SW, Kim KH, Han JK, Park YH: Pylorus-preservation decreases the extent of atrophy of remnant pancreas after pancreatoduodenectomy. HPB 1: 65–70, 1999
Richard C, Fitzgerld PJ, Carol B, Resenstock L, Lipkin L: Segmental division of the rat pancreas for experimental procedures. Lab Invest 13: 1303–1321, 1964
Rehfeld JF, Stadil F, Rubin B: Production and Evaluation of antibodies for the radioimmunoassay of gastrin. Scand J Clin Lab Invest 30: 221–232, 1972
Soeldner JS, Slone D: Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes 14: 771–779, 1965
Rehfeld JF: Gastrin in serum. Scand J Gastroenterol 8: 577–583, 1973
Albano JDM, Ekins RP, Maritz GB, Turner RC: A sensitive precise radioimmunoassay of serum insulin replying on charcoal separation of bound and free hormone moieties. Acta Endocrinol 70: 487–509, 1972
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275, 1951
Labarca C, Paigen K: A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344–352, 1980
Burton K: A study of the condition and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 62: 315–323, 1956
Freck A, Begg D: The estimation of ribonucleic acid using ultraviolet absorption measurements. Biochim Biophys Acta 108: 333–339, 1965
Mayston PD, Barrowman JA: Influence of pentagastrin on the pancreas in hypophysectomized rats. Gastroenterology 64: 391–399, 1973
Satoh H, Inatomi N, Nagaya H, Inada A, Nakamura N, Maki Y: Antisecretory and antinuclear activities of a novel proton pump inhibitor AG-1749 in dogs and rats. J Pharmacol Exp Ther 248: 806–815, 1988
Koop I, Eissele R, Richter S, Patberg H, Mossner J, Arnold R, Koop H: A new CCK-B/gastrin receptor antagonist acts as an agonist on the rat pancreas. Int J Pancreatol 15: 215–222, 1994
Niederau C, Niederau M, Williams JA: Gaendell JH. New proglumide-analogue CCK receptor antagonist: Very potent and selective for peripheral tissue. Am J Physiol 250(Gastrointest. Liver Physiol): G856–G860, 1986
Woodruff GN, Hughes J: Cholecystokinin antagonist. Annu Rev Pharmacol Toxicol 31: 469–501, 1991
Wank SA, Plsegna JR, de Weerth A: Brain and gastrointestinal cholecystokinin receptor family: Structure and functional expression. Proc Natl Acad Sci USA 89: 8891–8893, 1992
Xu G, Sumi S, Koike M, Tanigawa K, Nio Y, Tamura K: Role of endogenous hypergastrinemia in regenerating endocrine pancreas after partial pancreatectomy. Dig Dis Sci 41: 2433–2439, 1996
Bonner-Weir S, Trent DF, Weir GC: Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. J Clin Invest 71: 1544–1553, 1983
Martin JM, Lacy PE: The prediabetic period in partially pancreatectomized rats. Diabetes 12: 238–242, 1963 GASTRIN EFFECT ON PANCREAS 2139 Digestive Diseases and Sciences, Vol. 46, No. 10 (October 2001)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, SW., Kim, K.H., Park, SJ. et al. Endogenous Gastrin Stimulates Regeneration of Remnant Pancreas After Partial Pancreatectomy. Dig Dis Sci 46, 2134–2139 (2001). https://doi.org/10.1023/A:1011946411646
Issue Date:
DOI: https://doi.org/10.1023/A:1011946411646